UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

UCLA Institute of Urologic Oncology

Print
Email
Share

Testicular Cancer

Program Director:    Mark S. Litwin, MD, MPH

Overview

Testicular cancer is a disease in which cells become malignant (cancerous) in the male testis (the glands inside the scrotum that produce sperm and male hormones). It is the most common solid tumor diagnosed in men between the ages of 15 and 34 in the United States. Approximately 8,000 new cases are diagnosed each year, but fewer than 400 men die of the disease each year. Thanks to advances in treatment, the prognosis is excellent for most men diagnosed with testicular cancer. When found and treated early, more than 95 percent of men are cured.

The Institute of Urologic Oncology and UCLA's Testicular Cancer Program offer multidisciplinary, comprehensive care, and focuses on the whole patient. We offer personalized care that includes the latest treatments in surgery, chemotherapy and radiation therapy, and are committed to a team approach to caring for our patients. This includes well-coordinated efforts from our urologists, medical oncologists, radiation oncologists, pathologists, radiologists, nurses, and office staff.  Through UCLA's Simms-Mann Center of Integrative Oncology, we also offer mental health support services for patients and their families. All these resources allow for customized perspectives in deciding on the best treatment for each patient.

Highlights: Research & Achievements at UCLA Testicular Cancer Program

  • Establishment of a multi-disciplinary team to meet patients' clinical needs in urologic oncology, medical oncology, radiation oncology, and psychosocial adjustment.
  • Development of a long-term survivorship program specifically geared to young men after testicular cancer.
  • Incorporation of testicular cancer outcomes into an Institute-wide program of quality-of-life optimization.
  • Application of established quality-of-care metrics for the treatment of men with testicular cancer.

 

UCLA Rated One of the Top Hospitals in the Nation